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A B S T R A C T   
Background: Cadmium exposure has been associated with increased diabetes risk in several studies, though there 
is still considerable debate about the magnitude and shape of the association. 
Objective: To perform a systematic review and meta-analysis of observational studies investigating the relation 
between cadmium exposure and risk of type 2 diabetes and prediabetes, and to summarize data on the magnitude 
and shape of the association. 
Data source: After conducting an online literature search through October 1, 2021, we identified 42 eligible 
studies investigating the association between cadmium exposure and risk of diabetes and prediabetes. 
Study eligibility criteria: We included studies that assessed cadmium exposure through biomarker levels; examined 
type 2 diabetes or prediabetes among outcomes; and reported effect estimates for cadmium exposure for meta- 
analysis only. 
Study appraisal and synthesis methods: Studies were evaluated using ROBINS-E risk of bias tool. We quantitively 
assessed the relation between exposure and study outcomes using one-stage dose-response meta-analysis with a 
random effects meta-analytical model. 
Results: In the meta-analysis, comparing highest-versus-lowest cadmium exposure levels, summary relative risks 
(RRs) for type 2 diabetes were 1.24 (95% confidence interval 0.96–1.59), 1.21 (1.00–1.45), and 1.47 (1.01–2.13) 
for blood, urinary, and toenail matrices, respectively. Similarly, there was an increased risk of prediabetes for 
cadmium concentrations in both urine (RR = 1.41, 95% CI: 1.15–1.73) and blood (RR = 1.38, 95% CI: 
1.16–1.63). 
In the dose-response meta-analysis, we observed a consistent linear positive association between cadmium 
exposure and diabetes risk, with RRs of 1.25 (0.90–1.72) at 2.0 µg/g of creatinine. Conversely for blood cad-
mium, diabetes risk appeared to increase only above 1 µg/L. Prediabetes risk increased up to approximately 2 µg/ 
g creatinine above which it reached a plateau with RR of 1.42 (1.12–1.76) at 2 µg/g creatinine. 
Limitations and conclusions: This analysis provides moderate-certainty evidence for a positive association between 
cadmium exposure (measured in multiple matrices) and risk of both diabetes and prediabetes.   
1. Introduction 
Cadmium is a toxic metal released in the environment after both 
natural and anthropogenic activities, particularly in contaminated and 
industrial areas devoted to smelting and refining of metals, and the 
manufacturing of batteries, coatings, or plastics (ATSDR 2012; Cappel-
letti et al. 2016). Exposure to cadmium may occur through occupational 
activities, smoking, food, and air pollution (Chen et al. 2021; European 
Food Safety Authority 2012; Filippini et al. 2016; White et al. 2019). 
Smokers have higher concentrations of cadmium (Behera et al. 2014), 
whilst among non-smokers, food is the main source of exposure, espe-
cially cereals, vegetables, mollusks, and offals (Filippini et al. 2018; Kim 
et al. 2019). Generally, women and older individuals have a higher body 
burden of cadmium due to increased absorption among iron-deficient 
individuals, and greater accumulation with aging (Gallagher et al. 
2011; Kim et al. 2019). Cadmium is absorbed through the same mech-
anism as other elements like zinc and manganese transporters (Himeno 
et al. 2019). Despite the use of these latter physiological systems to enter 
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the body, cadmium has no biological role in humans. It accumulates 
primarily in the liver and kidney, which are considered the main targets 
of its toxicity (Cabral et al. 2021; Satarug 2018). 
Cadmium has been classified as carcinogenic to humans (Group 1) by 
the International Agency for Research on Cancer (IARC 2012) due to its 
established positive associations with lung and kidney cancers, and 
suggestive associations with prostate and breast cancers (Filippini et al. 
2019b; Filippini et al. 2020; Nawrot et al. 2015; Vinceti et al. 2007). For 
breast cancer, recent findings indicate that the increase in risk occurs 
only at high levels of cadmium exposure (Andersson et al. 2021). In 
addition to cancer, elevated cadmium concentrations have been asso-
ciated with an increased risk of chronic diseases, especially renal, bone, 
and cardiovascular diseases (Åkesson et al. 2014; Bimonte et al. 2021; Li 
et al. 2019; Söderholm et al. 2020; Tinkov et al. 2018). Adverse effects of 
cadmium were initially reported after occupational exposure and were 
limited to renal toxicity, due to its bioaccumulation in the kidney cortex, 
and bone disease, leading to osteomalacia and an increased risk of 
fractures (Järup and Åkesson 2009). Kidney failure and softening of 
bones are the main symptoms of the ‘itai-itai disease’ caused by cad-
mium poisoning through diet among individuals living in polluted 
mining areas in Japan (Ikeda et al. 2004). 
Even low-level cadmium exposure has been associated with athero-
sclerosis, hypertension, and metabolic syndrome leading to both car-
diovascular and cerebrovascular diseases (Åkesson et al. 2014; Bimonte 
et al. 2021; Li et al. 2019; Söderholm et al. 2020; Tinkov et al. 2018; Xu 
et al. 2021). In particular, cadmium may exert several pro-atherosclerotic 
effects through increased coronary artery calcification, subendothelial 
retention and oxidation of lipoproteins, endothelial dysfunction as well 
as prothrombotic and antifibrinolytic effects (Barregard et al. 2021; 
Fagerberg and Barregard 2021; Martins et al. 2021), even at relatively 
low levels of exposure. Indeed, studies suggest a positive association 
between elevated cadmium concentrations and type 2 diabetes (Satarug 
et al. 2017b; Tinkov et al. 2017). Although the mechanisms by which 
cadmium influences diabetes risk association are not clear, animal and 
laboratory evidence suggests that cadmium can injure pancreatic tissue 
and cause excess stimulation of gluconeogenesis, reduction of insulin 
incretion, and insulin resistance at target tissues, especially adipose tis-
sue, leading to decreased glucose uptake (Attia et al. 2021; Buha et al. 
2020; Edwards and Ackerman 2016; Hong et al. 2021; Moulis et al. 
2021). Epidemiological studies also suggest a positive association be-
tween cadmium and both type 2 and gestational diabetes (Guo et al. 
2019; Liu et al. 2018). In particular, a positive association between uri-
nary cadmium concentrations and type 2 diabetes has been shown at 
concentrations above 2.4 μg/g creatinine (Guo et al. 2019). However, no 
previous reviews have assessed the shape of the association between 
blood cadmium concentrations and type 2 diabetes using a dose-response 
approach and there has been no investigation of prediabetes as a distinct 
endpoint in these reviews. In recent years, greater attention has been 
given to adverse effects even at exposure levels previously considered 
safe as well as smoking-independent effects of cadmium exposure 
(Fagerberg and Barregard 2021; Satarug et al. 2017a). 
In this report, we provide an updated literature review of human 
studies on cadmium exposure and risk of both type 2 diabetes and pre-
diabetes, and we model the shape of these associations using a dose- 
response approach (Orsini and Spiegelman 2020). The research ques-
tion was configured according to PECOS statement (Population, Expo-
sure, Comparator(s), Outcomes, and Study design - “In adult populations, 
what is the incremental effect of cadmium exposure on risk of type 2 
diabetes or prediabetes from epidemiological nonexperimental studies?”) 
(Morgan et al. 2018). 
2. Methods 
We followed the Preferred Reporting Items for Systematic Reviews 
and Meta-Analysis (PRISMA) 2020 statement (Page et al. 2021) to 
perform this review. 
2.1. Literature search and screening 
We performed online literature searches in PubMed/MEDLINE, Web 
of Science, and EMBASE databases through October 1, 2021, by using 
search terms related to “cadmium” and “diabetes” or “prediabetes state”. 
Details about the search terms are reported in Supplemental Table S1. We 
further applied citation chasing techniques to identify relevant studies. 
We performed screening of reference lists of included papers as well as 
backward and forward citations of included studies (Booth 2008; Euro-
pean Network for Health Technology Assessment (EUnetHTA) 2019). 
Retrieved articles were imported into Rayyan QCRI online application 
and duplicates were removed. Two authors (TF and MV) independently 
screened publication titles and abstracts and evaluated full-text publi-
cations for inclusion in the review. In case of disagreement, both authors 
performed a second review of the full text to determine eligibility for 
inclusion through a consensus-based discussion. If the two authors still 
disagreed, a third author (LW) was sought to resolve disagreement. 
2.2. Eligibility criteria and study selection 
Inclusion criteria for studies in this review were: (1) cadmium expo-
sure assessment using any biomarker based on heavy metal concentra-
tion; (2) outcome of interest (type 2 diabetes or prediabetes); and for 
inclusion in the meta-analysis: (3) outcome identified using criteria 
defined by the World Health Organization (WHO 1999), the American 
Diabetes Association (American Diabetes 2021), or as follows: type 2 
diabetes: glycated hemoglobin A1c (HBA1c) ≥ 6.5%, fasting plasma 
glucose (FPG) ≥ 126 mg/dL or ≥ 7 mmol/L, or 2 h plasma glucose (2 h- 
PG) during oral glucose tolerance test (OGTT) ≥ 200 mg/dL or ≥ 11.1 
mmol/L; prediabetes (i.e., impaired glucose tolerance): HBA1c from 5.7% 
to 6.4%, FPG from 100 mg/dL to 125 mg/dL or from 5.6 to 6.9 mmol/L, 
or 2 h-PG during OGTT from 140 mg/dL to 199 mg/dL or from 7.8 to 
11.0 mmol/L; (4) reporting of relative risk estimates using the hazard 
ratio (HR), rate/risk ratio (RR), or odds ratio (OR), along with the cor-
responding 95% confidence interval (CI), or enough data to calculate 
them; and for inclusion in dose-response meta-analysis: (5) reported ef-
fect estimates for all exposure categories along with dose in each cate-
gory. We did not apply any language restrictions. When necessary, we 
also contacted authors of included studies to retrieve additional infor-
mation for data analysis when not published in the report. 
2.3. Risk of bias assessment 
We assessed the quality of included studies using the Risk of Bias for 
in Non-randomized Studies of Exposures (ROBINS-E) tool (Morgan et al. 
2019). Seven domains were considered including: (1) bias due to con-
founding; (2) bias in selecting participants in the study; (3) bias in 
exposure classification; (4) bias due to departures from intended expo-
sures; (5) bias due to missing data; (6) bias in outcome measurement; (7) 
bias in the selection of reported results. Supplemental Table S2 reports 
criteria for risk of bias evaluation. 
2.4. Data extraction 
We extracted the following data from eligible studies: (1) first author 
name; (2) publication year; (3) location; (4) type of exposure assess-
ment; (5) outcome of interest; (6) cadmium concentrations in the overall 
population and according diabetic/prediabetic status; (7) cut-off values 
for each category of exposure; (8) number of cases; (9) sample size; (10) 
relative risk estimates with 95% CIs and covariates from the most 
adjusted multivariable analysis when available. 
2.5. Synthesis of evidence 
We used qualitative and quantitative approaches to synthesize evi-
dence across studies. In the quantitative approach, we applied further 
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inclusion criteria as reported in Section 2.2. We used Stata software 
(v17.0, Stata Corp., College Station, TX, 2021) for all data analyses, 
specifically the ‘meta’, ‘mkspline’, and ‘drmeta’ routines. 
2.5.1. Meta-analysis 
We performed a meta-analysis that involved estimating RRs from 
each study, comparing the highest versus lowest exposure categories. 
We applied a restricted maximum likelihood random effects model. 
2.5.2. Dose-response meta-analysis 
We explored the shape of the association between cadmium exposure 
and risk of diabetes and prediabetes using a one-stage approach (Adani 
et al. 2020; Filippini et al. 2019a; Filippini et al. 2021). In this approach, 
we used the mean/median concentration or the midpoint of each 
exposure category depending on data availability. If the highest and 
lowest exposure categories were ‘open,’ we used as boundary a value 
that was 20% higher or lower, respectively, than the closest cutpoint 
(Vinceti et al. 2016). In the analysis on blood cadmium concentrations, 
all but one study provided data suitable for the dose-response meta- 
analysis assessing cadmium in whole blood. We also estimated blood 
cadmium from plasma cadmium concentrations in the only study using 
this biomarker, considering that 90% is bound to erythrocytes and the 
remaining is bound to metallothionein proteins in plasma (Deutsche 
Forschungsgemeinschaft 2006; Kjellström and Nordberg 1978; Nord-
berg et al. 1971). We used a restricted cubic spline model with 3 knots at 
fixed cutpoints (10, 50, and 90 percentiles). We also used a generalized 
least-squares regression model that accounted for the correlation within 
each set of published effect estimates through the restricted maximum 
likelihood method in a random-effects meta-analysis (Crippa et al. 2019; 
Orsini et al. 2012; Vinceti et al. 2020). 
2.5.3. Subgroup and sensitivity analyses 
We stratified all analyses by exposure matrix (i.e., blood or urine). 
Whenever possible, we also stratified the data by sex, geographic region 
(namely Asia, Europe, North America, Africa and Oceania to account for 
differences in ethnic origin or dietary habits), and study design (cross- 
sectional, case-control, and cohort). We ran sensitivity analyses using an 
alternative estimate (i.e., ±15% and ±10% instead of ±20%) for the 
highest and lowest exposure boundaries when median/mean values 
were not reported. We excluded studies that did not account for smoking 
in multivariate models, and studies judged to be at high risk of bias. 
Finally, in the dose-response analysis only, we assessed the presence of a 
linear trend in spline analyses (Orsini et al. 2012). 
2.5.4. Heterogeneity and small study bias assessment 
We assessed heterogeneity of studies using the τ2, I2 and H2 statistics 
(Higgins et al. 2003). For the dose-response analysis, we provided a 
graphical overlay of study-specific trends using predicted curves of 
analysis showing the influence of variation across studies (Crippa et al. 
2019). We also performed meta-regression analysis to further explore 
heterogeneity, in particular using as moderator cadmium concentrations 
in blood and urine. Finally, we evaluated the presence and influence of 
small-study bias using funnel plots with Egger’s test (Egger et al. 1997), 
and the trim-and-fill analysis (Duval and Tweedie 2000). 
2.6. Certainty of the evidence 
We assessed the overall certainty of the evidence using the GRADE 
approach (Atkins et al. 2004). Taking into account the PECO question, 
we assessed the certainty assessment for diabetes and prediabetes risk 
due to incremental cadmium exposure (assessed through blood or uri-
nary levels) yielded by the dose-response analysis in all studies and after 
excluding studies at high risk of bias. We used GRADEPro GDT 
(https://gradepro.org) to present the certainty assessment and summa-
rize findings in tabular form. 
3. Results 
3.1. Study selection 
The PRISMA checklist is reported in Supplemental Table S3. The 
PRISMA flow-chart of the literature search is presented in Fig. 1. We 
retrieved 1311 unique studies, from which 1241 were excluded after 
title and abstract screening. After full-text assessment of the remaining 
70 studies, 29 were further excluded because the outcome was not type 2 
diabetes or prediabetes (N = 13); the exposure assessment did not 
include cadmium (N = 6); or the publication was a duplicate (N = 5), a 
preliminary report of a subsequently included study (N = 4), or a 
commentary (N = 1). One study was added through backward citation 
searching of included studies (Tadayon et al. 2013). 
3.2. Characteristics of included studies in the review 
Summary characteristics of the 42 included studies are reported in 
Table 1. Overall, studies were published between 1992 and 2022, with 
most from Asia (N = 22), followed by North America (N = 8) and South 
America (N = 1), Europe (N = 6), Africa (N = 2) Oceania (N = 1), and 
multiple geographic regions (N = 2). Cadmium concentrations were 
measured in urine (N = 21), blood (N = 18), hair (N = 4), nails (N = 2), 
tears (N = 1) or adipose tissue (N = 1), with two studies assessing 
exposure in both hair and nails (Sukumar and Subramanian 1992; 
2007), two studies in both urine and blood (Afridi et al. 2008; Barregard 
et al. 2013), and one study in blood, urine, and hair (Flores et al. 2011). 
Diabetes was investigated as an outcome in thirty-one studies, predia-
betes in four studies, and both diabetes and prediabetes in seven studies. 
Thirteen studies (all assessing diabetes only) did not report enough data 
to assess risk estimates, thus the meta-analysis could not be performed 
(Adams et al. 2016; Afridi et al. 2008; Akinloye et al. 2010; Anetor et al. 
2016; Flores et al. 2011; Hotta et al. 2019; Joda and Ward 2021; Serdar 
et al. 2009; Skalnaya et al. 2017; Sukumar and Subramanian 1992; 
2007; Tadayon et al. 2013; Zhu and Hua 2020). 
3.3. Risk of bias assessment 
Results of study quality assessment by risk of bias are reported in 
Table 2. Overall, seven of the included studies were deemed to be at 
high risk of bias (Adams et al. 2016; Haswell-Elkins et al. 2007; Joda 
and Ward 2021; Lei et al. 2019; Moon et al. 2022; Saba et al. 2020; 
Swaddiwudhipong et al. 2010). Thirteen studies (Adams et al. 2016; 
Afridi et al. 2008; Akinloye et al. 2010; Anetor et al. 2016; Flores et al. 
2011; Hotta et al. 2019; Joda and Ward 2021; Serdar et al. 2009; 
Skalnaya et al. 2017; Sukumar and Subramanian 1992; 2007; Tadayon 
et al. 2013; Zhu and Hua 2020) did not report relative risk estimates for 
diabetes or prediabetes, and did not provide row data to calculate them. 
One study was considered at moderate risk of bias due to lack of control 
for smoking (Schwartz et al. 2003) and additional four studies were 
considered at high risk of bias due to confounding, since one study did 
not adjust for age (Saba et al. 2020), and three did not use multivariable 
model (Haswell-Elkins et al. 2007; Lei et al. 2019; Swaddiwudhipong 
et al. 2010). Nonetheless, for the latter three studies, we used crude 
data in the analysis. We cannot exclude selection bias as a source of bias 
in six studies conducted among individuals living in cadmium- 
contaminated areas; these studies were considered at moderate risk 
of bias. Regarding information bias, risk of exposure misclassification is 
unlikely because all studies assessed cadmium exposure though anal-
ysis of biological specimens at the beginning of the study. With respect 
to bias in departure from intended exposure, none of the study was at 
high risk of bias because it did not report mean values of cadmium 
exposure. None of the studies excluded participants due to missing data 
≥20%. Outcome identification was based on self-report in two studies 
(Adams et al. 2016; Moon et al. 2022), and another three studies re-
ported no information about method of outcome ascertainment (Joda 
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and Ward 2021; Lei et al. 2019; Tadayon et al. 2013) thus they were 
considered at high risk of bias. 
3.4. Quantitative synthesis 
3.4.1. Diabetes 
Analyses comparing highest versus lowest concentrations of cadmium 
showed a positive association with diabetes independent from exposure 
assessment method, with RR of 1.24 (95% CI 0.96–1.59, 9 studies), 1.21 
(95% CI 1.00–1.45, 15 studies), and 1.47 (95% CI 1.01–2.13, one study) 
for blood, urine, and toenail matrices, respectively (Fig. 2). Analyses 
stratified by region suggested somewhat higher risk estimates in North 
American populations (based on one study only), followed by Asian 
populations in studies using blood cadmium concentrations. Conversely, 
a stronger association was observed in Oceania populations (based on 
one study only), followed by Asian populations using urinary cadmium 
concentrations for exposure assessment (Supplemental Figure S1-S2). 
Conversely, analyses stratified by sex showed comparable risk estimates 
for both men and women (Supplemental Figure S3), though these results 
were based on fewer studies compared with the main analysis. Similarly, 
we found comparable results among men and women when we consid-
ered studies reporting RRs estimated for both sexes (Supplemental 
Figure S4). Analyses stratified by study design showed generally stronger 
RRs when considering case-control and cross-sectional studies compared 
with cohort studies (Supplemental Figures S5-S6). 
In the dose-response meta-analysis, we detected a substantial linear 
positive association with diabetes risk for increasing levels of urinary 
cadmium. Compared with no exposure, RRs were 1.07 (95% CI 
0.95–1.20), 1.13 (95% CI 0.91–1.41), 1.25 (95% CI 0.90–1.72), and 1.42 
(95% CI 0.93–2.17) at concentrations of 0.5, 1.0, 2.0, and 4.0 µg/g 
creatinine, respectively (Fig. 3). Conversely for blood concentrations, 
the RR increased at values above 1 µg/L compared with no exposure, 
with RRs of 0.92 (95% CI 0.61–1.40), 1.47 (95% CI 0.79–2.76), 2.43 
(05% CI 0.91–6.51), and 4.00 (95% CI 1.00–16.01) at 1.0, 1.5, 2.0 and 
2.5 µg/L, respectively (Fig. 3). 
3.4.2. Prediabetes 
With regard to prediabetes, we found a positive association for cad-
mium concentrations in both urine (RR 1.41, 95% CI 1.15–1.73, 8 
studies) and blood (RR 1.38, 95% CI 1.16–1.63, 3 studies) when 
comparing the highest versus lowest exposure categories (Fig. 4). Simi-
larly, a positive association can be noted in the dose-response meta- 
analysis: compared to no exposure, RRs increased up to approximately 2 
µg/g creatinine, above which a plateau was reached, with RRs of 1.12 
(95% CI 1.03–1.21), 1.23 (95% CI 1.06–1.43), 1.40 (95% CI 1.12–1.76), 
and 1.55 (95% CI 1.21–1.99) at 0.5, 1.0, 2.0, and 4.0 µg/g creatinine, 
respectively (Fig. 5). In the region-stratified analyses, we found similar 
RRs among different regions on blood studies, whilst we found a some-
what stronger RR among North Americans than Asians in studies that 
assessed urinary cadmium concentrations (Supplemental Figures S7-S8). 
The three studies that assessed blood cadmium concentrations all had 
cross-sectional designs, as did the majority of studies using urinary 
excretion (one cohort and seven cross-sectional studies). In urinary 
excretion studies, substantially stronger associations were observed for 
cross-sectional studies (Supplemental Figure S9). 
3.4.3. Sensitivity analyses 
In sensitivity analyses using a value ±15% or ±10% instead of 20% 
to the closest (lower and upper) available boundary in open categories, 
we found comparable results (Supplemental Figures S10-S13). After 
Fig. 1. Flow-chart of systematic literature search through October 1, 2021.  




Characteristics of the included studies divided by type of cadmium (Cd) exposure assessment and ordered by first author’s name and publication year.  














Blood Cd    µg/L µg/L    
(Afridi et al. 2008) Pakistan 434 men from Hyderabad aged 
31–60 years: 238 non-DM (115 
non-smokers, 123 smokers) and 







DM: 5.7 (1.3) 
smokers: 
non-DM: 5.3 (1.4) 
DM: 8.9 (1.2) 
NR NR FPG, HbA1c NR 
(Akinloye et al. 2010) Nigeria 90 subjects(40 non-DM, 50 DM) 
from LAUTECH Teaching Hospital, 
Osogbo 
Case-control non-DM: 0.64 
(0.18) 
DM: 0.80 (0.16) 
NR NR FPG NR 
(Anetor et al. 2016) Nigeria 65 subjects, 20 non-DM, 45 DM 
mean age 57 and 62 years, 




DM: 0.50 (0.201) 
NR NR FPG, HbA1c NR 
(Barregard et al. 
2013) 
Sweden 616 women from Gothenburg aged 


























FPG, OGTT, HbA1c pack-years of smoking, waist circumference, and 
serum adiponectin 
(Borne et al. 2014) Sweden Malmo Diet and Cancer Study: 
4585 subjects (M/F: 1831/2754) 



































age, waist circumference, and smoking status 
(Ettinger et al. 2014) Ghana, South 
Africa, 
Seychelles, 
Jamaica and US 
METS study: 150 African descent 
young adults aged 25–45 years (99 
non-DM, 51 pre-DM) 
Cross- 
sectional 









1.69 (0.77–3.68) FPG age, sex, site location, marital status, education, 
paid employment, smoking, alcohol use, and fish 
intake 
(Flores et al. 2011) Mexico 88 subjects from Department of 
Medical Research, University of 






DM: 0.13 (0.48) 
NR NR FPG, HbA1c NR 
(Hansen et al. 2017) Norway  HUNT3 study: 883 subjects ≥ 20 





age, sex, BMI, waist-to-hip ratio, education, 
income, smoking and family history of diabetes 
(continued on next page) 
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Table 1 (continued ) 






















(+HbA1c in cases 
only) 
(Ji et al. 2021) South Korea Changwon industrial city: 34,814 





DM: 2 µg/L 
NR 1.48 (0.61–3.55) FPG, HbA1c, 
history of DM 
age, hemoglobin A1c, fasting blood sugar, BMI, 
current smoking, and ferritin 
(Li et al. 2017) China 551 subjects from Suzhou City, 
Jiangsu Province, mean age 66 
















FPG, OGTT, HbA1c age, sex, BMI, family history, smoking and 
drinking status 
(Little et al. 2020) US Superfund Cleanup in Dallas, TX: 
875 subjects aged 19–88 years (766 






NR 1.85 (1.14–2.99) HbA1c age, sex, smoking tobacco, duration of residence, 
smelter workers, lead blood level, arsenic blood 
level, mercury blood level, abnormal GGT, 
hypertension 
(Moon 2013) South Korea KNHANES 2007–2012 study: 3284 
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based) 
age, sex, region, smoking, alcohol consumption 
and regular exercise 
(Nie et al. 2016) China  SPECT-China study: 5544 subjects 
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smoker, hypertension, dyslipidemia, estimate 
glomerular filtration rate, blood lead, and BMI 
(Serdar et al. 2009) Turkey 87 subjects aged 30–70 years (22 
non-DM, 20 IGT, 14 IFG, 31 DM) 








NR NR FPG, OGTT, HbA1c NR 
(Simić et al. 2017) Norway  HUNT3 study: 868 subjects ≥ 20 














FPG, OGTT matched by sex and age, and adjusted for BMI, 
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diabetes, smoking habits, area, education and 
economic status 
(Skalnaya et al. 
2017) 
Russia 128 postmenopausal women living 
in Moscow men age 56 years (64 






NR NR HbA1c NR 
(Son et al. 2015) South Korea HESRAM study: 719 (M/F: 489/ 
230) residents of abandoned metal 
mines aged 40–70 years (561 non- 
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(continued on next page) 
T. Filippini et al.                                                                                                                                                                                                                                
EnvironmentInternational158(2022)106920
7
Table 1 (continued ) 
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Urinary Cd    µg/g creatinine     
(Adams et al. 2016) US 188 adults (M/F: 26/160) aged 
40–85 years from New Mexico, 







DM: 0.41 (0.37) 
NR NR History of DM 
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NR 
(Afridi et al. 2008) Pakistan 434 men from Hyderabad aged 
31–60 years: 238 non-DM (115 
non-smokers, 123 smokers) and 
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2013) 
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FPG, OGTT, HbA1c pack-years of smoking, waist circumference, and 
serum adiponectin 
(Feng et al. 2015) China 2242 subjects aged 18–80 years 
from Wuhan city (1765 non-DM, 






















of DM (physician- 
based) 
age, sex, BMI, smoking status, pack year, alcohol 
status, family history of diabetes, diabetic drug 















age, sex, BMI, smoking status, pack year, alcohol 
status, family history of diabetes, hypertension, 
hyperlipidemia, and urinary creatinine 
(Flores et al. 2011) Mexico 88 subjects from Department of 
Medical Research, University of 





DM: 0.13 (0.12) 
NR NR FPG and HbA1c NR 
(Haswell-Elkins et al. 
2007) 
Australia Torres Strat Islanders: 182 (M/F: 
58/124) subjetcs aged 37 years 

















FPG, OGTT crude 
(Jiang et al. 2018) US  NHANES 









FPG, OGTT, and 
HbA1c 
age, sex, race/ethnicity, poverty income ratio, 
smoking status, alcohol consumption, physical 
activity and BMI 
(continued on next page) 
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Table 1 (continued ) 














1783/1769) aged 20–60+ (2132 











(Lei et al. 2019) China 593 (M/F: 215/378) subjects mean 
age 63 years, 427 (M/F: 62/104) 
non-DM, 166 (M/F: 153/274) DM 






NR 1.61 (1.08–2.41) FPG, OGTT, and 
DM treatment 
crude 
(Liu et al. 2016) China 1595 coke oven workers in Wuhan 

























of DM (physician- 
based) 
sex, age, BMI, smoking status, drinking status, 
physical activity, education levels, urinary 
creatinine, hypertension, hyperlipidemia, and 
urinary polycyclic aromatic hydrocarbons levels 
(Menke et al. 2016) US  NHANES 1999–2010 study: 9447 
subjects aged ≥ 20 years (8083 
















HbA1c age, race-ethnicity, sex, menopausal status, 
education, income, alcohol consumption, smoking 
status, pack years smoked, waist circumference, 
high alanine aminotransferase, high gamma 
glutamyl transferase, daily calories consumed, 
percent of calories from saturated fat, and C- 
reactive protein 
(Moon et al. 2022) South Korea KoNEHS 2015–2017 study: 3787 
(M/F: 1648/2139) participants 



















age, sex, cigarette smoking, alcohol drinking, 
exercise, and education levels 
(Saba et al. 2020) Pakistan 724 participants aged > 40 years 













FPG, HbA1c education, sex, job, smoking and urinary heavy 
metal concentration 
(Schwartz et al. 
2003) 
US NHANES III: 
8112 subjects (6905 non-DM, 610 















FPG age, sex, ethnicity, and BMI 
(Son et al. 2015) South Korea HESRAM study: 719 (M/F: 489/ 
230) residents of abandoned metal 
mines aged 40–70 years (561 non- 




all: 2.29 (2.20) 

















FPG age, BMI, smoking, alcohol consumption, region, 
family income (and menopausal status in women) 
(continued on next page) 
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Table 1 (continued ) 















et al. 2010) 
Thailand 5273 (M/F: 2370/2903) subjects 





all: 2.2 (2.3) 
men: 2.0 (2.2) 











et al. 2015) 
Thailand 535 rural population in Cd exposed 
(258) and non-exposed (277) 

















of DM (physician- 
based) 
sex, age, chronic kidney disease, protein 
excretion, calcium excretion, BMI, drinking, and 
smoking 
(Velmurugan et al. 
2018) 
India 865 subjects from typical farming 
village in Tamil Nadu aged > 20 
























of DM (physician- 
based) 
age, sex, education, occupation, waist 
circumference, BMI, diastolic and systolic blood 
pressure, low-density lipoprotein- cholesterol, 
familial diabetic history, smoking, and alcohol 
and tobacco usage. 
(Wallia et al. 2014) US NHANES 2005–2010: 2398 (M/F: 
1194/1204) subjects aged ≥ 40 





















FPG, OGTT, HbA1c age, race/ethnicity, sex, education, BMI, 
hypertension, smoking status, pack-years, and 
survey year 
(Wang et al. 2020) US SWAN study: women aged 42–52 
years at enrollment: 1237 at 15th 









risk for twofold 
cadmium 
increase 
0.96 (0.86–1.07) HbA1c, DM 
treatment, history 
of DM (physician- 
based) 
age, race/ethnicity, study site, and specific 
gravity, education, household income, body mass 
index (baseline level), waist circumference 
(baseline level), smoking status, alcohol 
consumption, physical activity score, total energy 
intake, menopausal status, and use of hormone, 
seafood and rice intake 
(Xiao et al. 2021) China Wuhan-Zhuhai cohort: 3521 urban 














FPG, HbA1c, DM 
treatment, history 
of DM (physician- 
based) 
sex, age, BMI, education, smoking status, drinking 
status, physical activity, and family history of 
diabetes 
(Yang et al. 2017) China Jinchang Cohort: 464 (M/F: 236/ 
238) metal-exposed workers aged 
20-50 years, 334 (M/F: 155/179) 

















sex, age, education, occupation, BMI, pack-years, 
current drinker, family history of diabetes, 
abnormal lipid, C-reactive protein, hypertension, 
urinary creatinine level, and arsenic, cobalt, 
copper, nickel and zinc fitted simultaneously  
Hair Cd    µg/g µg/g    
(Afridi et al. 2008) Pakistan  
434 men from Hyderabad aged 
31–60 years: 238 non-DM (115 
non-smokers, 123 smokers) and 







DM: 2.5 (0.26) 
smokers: 
non-DM: 1.98 
NR NR FPG, HbA1c NR 
(continued on next page) 
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Table 1 (continued ) 















DM: 3.18 (0.83) 
(Hotta et al. 2019) Japan 96 residents in Hokkaido, Aomori, 
Miyagi and Iwate Prefectures and 
the Tokyo Metropolitan area, 54 






DM: 0.019 (0.027) 




India Urban residents of New Delhi: 129 
(M/F: 29/100) subjects, 100 (M/F: 







non-DM: 0.8 (0.2) 




DM: 0.8 (0.2) 




India 154 /M/F: 72/82) subjects from 









NR NR History of DM NR 




Levels higher in 
DM than non-DM 
(figure only) 
NR NR NR NR  




India 67 (M/F: 30/37) urban residents of 







non-DM: 1.1 (0.2) 
DM: 1.0 (0.4) 
women 
non-DM: 1.2 (0.2) 
DM: 0.9 (0.5) 




India 154 (M/F: 72/82) subjects from 









NR NR History of DM NR 
(Xun et al. 2013) US CARDIA study: prospective cohort 
of 3,898 American young adults, 
aged 20–32 years, free of diabetes 














FPG, OGTT, HbA1c age, sex, ethnicity, study center, education, serum 
cotinine, alcohol consumption, physical activity, 
family history of diabetes, BMI, the ratio of low to 
high density lipoprotein cholesterol, and baseline 
homeostatic model assessment  
Teardrop Cd    µg/L µg/L    
(Joda and Ward 
2021) 
Iraq and UK 111 (M/F: 42/69) healthy controls 
and 44 (M/F: 18/26) DM from 
Karbala (Iraq) plus 18 (M/F: 12/6) 
healthy controls from UK aged 3–75 
years 
Case-control non-DM Iraq: 1.9 
(1.7) 
non-DM UK: 3.8 
(2.7) 
DM: 2.2 (2.21) 
NR NR NR NR  
Adipose tissue Cd    ng/g ng/g    
(continued on next page) 
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excluding studies that did not adjust for smoking, results were largely 
unchanged for both diabetes and prediabetes in both the highest versus 
lowest exposure category comparison (Supplemental Figures S14-S15) 
and in the dose-response meta-analysis (Supplemental Figures S16-S17). 
Exclusion of studies at high risk of bias (all assessing diabetes) showed 
almost identical results (Supplemental Figures S18-S19). Analyses 
stratified by whole blood and plasma showed stronger RRs for the latter, 
though based on only one study (Supplemental Figure S20), while the 
analysis restricted to whole blood showed substantial similar results to 
the overall analysis, in both the forest plot and in the dose-response 
meta-analysis (Supplemental Figures S20-S21). 
Study-specific lines in dose-response relations, in addition to the 
overall dose-response meta-analyses, demonstrated substantial homo-
geneity (Supplemental Figures S22-S23), with partial exceptions for 
estimates from studies using blood (N = 2) and urinary (N = 1) cadmium 
concentrations, respectively (Supplemental Figure S22). Comparisons of 
spline and linear regression analyses of the relation between cadmium 
and diabetes showed slightly different patterns for blood exposure, with 
a RR of 1.29 (95% CI 0.95–1.74) for every 1 µg/L increase in blood 
concentrations for all studies, none at high risk of bias (Supplemental 
Figure S24). Conversely, a similar trend was noted for urinary cadmium, 
with RRs of 1.10 (95% CI 0.99–1.21) for every 1 µg/g creatinine increase 
of urinary levels considering all studies (Supplemental Figure S24) and 
1.14 (95% CI 1.04–1.25) after exclusion of studies at high risk of bias 
(Supplemental Figure S25). For prediabetes, the linear trend showed a 
monotonic increase with no indication of the plateau suggested by dose- 
response analysis, with a RR of 1.15 (95% CI 1.04–1.27) for every 1 µg/g 
creatinine increase in urinary cadmium concentrations for all studies, 
none at high risk of bias (Supplemental Figure S26). 
The meta-regression analysis showed little association between blood 
cadmium concentrations and diabetes risk, but a positive though very 
imprecise association was observed with increasing urinary cadmium con-
centrations (Supplemental Figure S27). Similarly, though based on a limited 
number of studies, we found no appreciable association between blood 
cadmium concentrations and risk of prediabetes, while we found a positive 
relation with urinary cadmium concentrations (Supplemental Figure S28). 
3.4.4. Small-study bias assessment 
Funnel plots based on the different exposure assessment methods 
indicated moderate small-study effects for studies investigating diabetes 
using urinary cadmium (Supplemental Figure S29), but almost negli-
gible effects for diabetes and blood cadmium (Supplemental Figure S29) 
and prediabetes (Supplemental Figure S30). After exclusion of the 
studies at high risk of bias in diabetes analysis, the magnitude of Egger’s 
test decreased, though still suggesting some possible small-study effect 
for urinary cadmium (Supplemental Figure S31). Trim-and-fill analyses 
showed identical results for blood cadmium and diabetes, while results 
were weaker for urinary cadmium with the addition of two inputted 
studies (RR 1.15, 95% CI 0.95–1.41). Conversely, trim-and-fill analysis 
for either blood or urinary cadmium with prediabetes showed no dif-
ference with the original estimates. 
3.5. Certainty of the evidence 
There were no major issues due to inconsistency, indirectness, or 
imprecision for either outcome in the GRADE assessment (Table 3). Risk 
of bias was of concern in analyses of all studies for diabetes risk due to 
increased urinary cadmium levels, since two studies have been rated at 
high risk of bias. In all scenarios, we upgraded the evidence due to 
presence of dose-response gradient. Overall, when all studies were 
considered, there was moderate-certainty of the evidence for increased 
risk of type 2 diabetes due to increase of blood cadmium levels, but low- 
certainty for increasing urinary cadmium concentrations. For predia-
betes, there was moderate-certainty due to increasing urinary cadmium 
concentrations. After excluding studies at high risk of bias, we found 
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4. Discussion 
Overall, we found consistent epidemiological evidence that higher 
cadmium exposure was associated with increased risks of both diabetes 
and prediabetes. However, the positive associations were found mainly 
in cross-sectional and case-control studies; cohort studies indicated 
weaker evidence for an association. In the dose-response meta-analysis, 
we found evidence of a positive association for the highest cadmium 
blood concentrations (above 2 µg/L) and monotonic linear increase in 
risk in studies that measured urinary cadmium concentrations. 
Possible explanations for the different patterns of association be-
tween blood and urinary cadmium concentrations with respect to risk of 
diabetes might be due to the properties of each biomarker, with urinary 
cadmium generally reflecting longer-term accumulation, while blood 
levels tend to reflect more recent exposure (Järup and Åkesson 2009). 
Additionally, for blood cadmium concentrations, we considered studies 
Table 2 
Risk of bias assessment using Risk of Bias for in Non-randomized Studies of Exposures (ROBINS-E) tool.  
Studies Type of 
exposure 
assessment 




























(Adams et al. 2016) U NA Low Low Moderate Low High Low High 
(Afridi et al. 2008) B, U, H, NA Low Low Moderate Low Low Moderate Low 
(Akinloye et al. 
2010) 
B NA Low Low Moderate Low Low Moderate Low 
(Anetor et al. 2016) B NA Low Low Moderate Low Low Moderate Moderate 
(Barregard et al. 
2013) 
B, U Low Low Low Low Low Low Low Low 
(Borne et al. 2014) B Low Low Low Low Low Low Low Low 
(Ettinger et al. 
2014) 
B Low Low Low Low Low Low Low Low 
(Feng et al. 2015) U Low Low Low Low Moderate Low Low Moderate 
(Flores et al. 2011) B, U NA Low Low Moderate Low Low Moderate Moderate 
(Hansen et al. 2017) B Low Low Low Moderate Low Low Low Moderate 
(Haswell-Elkins 
et al. 2007) 
U High Low Low Low Low Low Low High 
(Hotta et al. 2019) H NA Low Low Moderate Low Low Moderate Moderate 
(Ji et al. 2021) B Low Moderate Low Moderate Low Low Low Moderate 
(Jiang et al. 2018) U Low Low Low Moderate Moderate Low Low Moderate 
(Joda and Ward 
2021) 
T NA Moderate Low Moderate Low High Moderate High 
(Lei et al. 2019) U High Low Low Moderate Low High Moderate High 
(Li et al. 2017) B Low Low Low Low Moderate Low Moderate Moderate 
(Little et al. 2020) B Low Moderate Low Moderate Low Low Moderate Moderate 
(Liu et al. 2016) U Low Moderate Low Low Low Low Moderate Moderate 
(Menke et al. 2016) U Low Low Low Low Low Low Low Low 
(Moon 2013) B Low Low Low Low Low Low Low Low 
(Moon et al. 2022) U Moderate Low Low Low Low High Low High 
(Nie et al. 2016) B Low Low Low Low Moderate Low Low Moderate 
(Saba et al. 2020) U High Low Moderate Low Low Low Moderate High 
(Salcedo-Bellido 
et al. 2021) 
AT Low Low Low Low Low Low Low Low 
(Schwartz et al. 
2003) 
U Moderate Low Low Low Low Low Low Moderate 
(Serdar et al. 2009) B NA Low Low Moderate Low Low Moderate Moderate 
(Simić et al. 2017) B Low Low Low Moderate Low Low Low Moderate 
(Skalnaya et al. 
2017) 
B NA Low Low Moderate Low Low Moderate Moderate 








H, N NA Low Low Moderate Low Low Moderate Moderate 
(Swaddiwudhipong 
et al. 2010) 
U High Low Low Low Low Low Moderate High 
(Tadayon et al. 
2013) 
H NA Low Low Moderate Low High Moderate High 
(Tangvarasittichai 
et al. 2015) 
U Low Moderate Low Moderate Low Low Moderate Moderate 
(Velmurugan et al. 
2018) 
U Low Low Low Low Low Low Low Low 
(Wallia et al. 2014) U Low Low Low Low Low Low Low Low 
(Wang et al. 2020) U Low Low Low Moderate Moderate Low Low Moderate 
(Xiao et al. 2021) U Low Low Low Low Low Low Low Low 
(Xun et al. 2013) N Low Low Low Low Low Low Low Low 
(Yang et al. 2017) U Low Moderate Low Low Low Low Low Moderate 
(Zhu and Hua 2020) B NA Moderate Low Low Low Low Moderate Moderate 
AT: adipose tissue; B: blood; H: hair; N: nails; T: tears; U: urine. NA: not assessed, no risk estimates reported in the study. 
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Fig. 2. Forest plot for diabetes risk by type of exposure assessment. RR: risk ratio; CI: confidence interval; HighExp: cadmium concentrations in the highest category. 
Values in µg/L, µg/g creatinine, and µg/g for blood, urinary and toenail cadmium concentrations, respectively. 
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assessing exposure through either whole blood or plasma levels. Despite 
some heterogeneity of these two methodologies, we found comparable 
results across both exposure matrices. 
Studies comparing blood and urinary concentrations report that they 
are generally positively-correlated (Adams and Newcomb 2014; Aker-
strom et al. 2013; Julin et al. 2011; Shimbo et al. 2000). However, blood 
levels may only partially explain the variation in urinary concentrations 
(Adams and Newcomb 2014), especially among non-occupational and 
low-exposed individuals, in whom there was a weaker to null correlation 
(Olsson et al. 2002; Shimbo et al. 2000). Conversely, at higher cadmium 
exposure, above 1.3–1.8 µg/L of blood levels, corresponding to approx-
imately to 2.2–2.6 µg/g creatinine (Higashikawa et al. 2000), the cor-
relation is generally stronger. This may due to accumulation of cadmium 
in the kidney, accounting for approximately half of the total cadmium 
body burden. After absorption from gastrointestinal tract to the blood-
stream, cadmium binds plasma proteins like albumin and transferrin, it is 
transported to the liver where it is bound to metallothionein (Li et al. 
2020). The cadmium-metallothionein complex is filtered in the renal 
glomerulus, is reabsorbed by tubular cells, and accumulates in the kidney 
cortex with a biological half-life of 10–30 years (Järup and Åkesson 
2009; Nawrot et al. 2010). Therefore, for chronic diseases with long la-
tency periods, use of blood concentrations for exposure assessment would 
likely attenuate the risk estimates (Adams and Newcomb 2014), while 
urinary cadmium concentrations are considered a more reliable 
biomarker of exposure (Åkesson et al. 2014; Satarug et al. 2017a), 
characterized by temporal stability and high correlation with total body 
burden (Akerstrom et al. 2013; Meliker et al. 2019). 
Our study assessed for the first time evidence of a dose-response 
relation between urinary cadmium concentrations and prediabetes sta-
tus. This finding is not entirely unexpected since most previous studies 
suggest a dose-response association (Jiang et al. 2018; Nie et al. 2016; 
Velmurugan et al. 2018; Wallia et al. 2014). However, we demonstrated 
that risk appears to increase in a linear manner up to approximately 2 
µg/g creatinine, while further elevation of cadmium concentrations was 
associated with little increase in risk. 
There is a biological plausibility for exposure to environmental fac-
tors like cadmium and the pathogenesis of type 2 diabetes. Cadmium 
may exert a toxic effect through damage of pancreatic beta cells, causing 
islet dysfunction and impaired insulin release (Edwards and Ackerman 
2016; Fitzgerald et al. 2020). Although most cadmium is found in the 
kidney, chronic exposure is associated with cadmium accumulation in 
the pancreas, and specifically in beta islets. Damage to the pancreas may 
be responsible for an increase of blood glucose along with a decrease in 
insulin levels (Kurata et al. 2003; Tinkov et al. 2017). Several underlying 
mechanisms have been proposed, including impairment of energy 
metabolism and antioxidant system, inflammation, and mitochondrial 
damage of pancreatic beta cells (Buha et al. 2020; Edwards and Acker-
man 2016). Some studies also suggest that cadmium may stimulate 
gluconeogenesis though increased activity of the gluconeogenic en-
zymes, and may decrease insulin sensitivity by altering expression of 
glucose transporter leading to decrease uptake of glucose (Edwards and 
Ackerman 2016). 
The dose-response modeling of cadmium exposure allowed us to 
investigate the dose-response relation with diabetes and prediabetes. A 
similar dose-response assessment was performed in a previous study, but 
it was based on urinary concentrations only and on a smaller number of 
reports (Guo et al. 2019). Conversely, our analysis took advantage of 
availability of additional data and, to our knowledge, was the first to 
investigate the shape of the association with prediabetes status. Persis-
tence of a positive association after exclusion of studies at high risk of 
bias lends credibility to our findings. 
Due to limited data (i.e., only three published studies), we could not 
assess the dose-response relation between blood levels and prediabetes 
risk. Also, the limited number of studies reporting sex-stratified results 
hampered the investigation of possible interaction between sex and the 
diabetogenic effects of cadmium. Another limitation was the different 
control variables included in the multivariate models, though most 
studies appropriately accounted for cigarette smoking, which represents 
a relevant source of cadmium exposure. Cigarette smoking may also 
increase risk of diabetes via inflammation, oxidative stress and free 
radical levels, and possibly direct injury of beta cells (Śliwińska-Mossoń 
and Milnerowicz 2017). However, contrasting findings have been re-
ported in the only studies of cadmium and diabetes risk that carried out 
analyses stratified by smoking status. In particular, cadmium exposure 
was associated with higher diabetes risk among never and former 
smokers in some studies (Borne et al. 2014; Xiao et al. 2021), and cur-
rent smokers in another study (Nie et al. 2016). Also, no difference by 
smoking history has been reported (Wang et al. 2020). Nonetheless, a 
recent paper investigating the relation between blood cadmium con-
centrations and glycated haemoglobin levels showed a positive associ-
ation, especially among never smokers, thus supporting the hypothesis 
of an independent relation of cadmium with diabetes, independent of 
tobacco use (Trouiller-Gerfaux et al. 2019). Conversely for prediabetes, 
a higher risk among smokers as compared with non-smokers has been 
reported (Wallia et al. 2014). Nonetheless, almost all studies included 
Fig. 3. Dose-response meta-analysis between cadmium exposure and diabetes 
using blood (A) (Barregard et al. 2013; Borne et al. 2014; Hansen et al. 2017; Li 
et al. 2017; Moon 2013; Nie et al. 2016; Simić et al. 2017) or urinary con-
centrations (B) (Barregard et al. 2013; Feng et al. 2015; Haswell-Elkins et al. 
2007; Liu et al. 2016; Menke et al. 2016; Moon et al. 2022; Saba et al. 2020; 
Schwartz et al. 2003; Son et al. 2015; Swaddiwudhipong et al. 2010; Tang-
varasittichai et al. 2015; Velmurugan et al. 2018). Spline curve (solid line) with 
95% confidence limits (grey area). RR: risk ratio. 
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Fig. 4. Forest plot for prediabetes risk by type of exposure assessment. RR: risk ratio; CI: confidence interval; HighExp: cadmium concentrations in the highest 
category. Values in µg/L and µg/g creatinine for blood and urinary cadmium concentrations, respectively. 
Fig. 5. Dose-response meta-analysis between cadmium exposure and pre-diabetes using urinary concentrations (Barregard et al. 2013; Feng et al. 2015; Jiang et al. 
2018; Liu et al. 2016; Schwartz et al. 2003; Velmurugan et al. 2018; Wallia et al. 2014; Yang et al. 2017). Spline curve (solid line) with 95% confidence limits (grey 
area). RR: risk ratio. 
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smoking among adjustment factors, and the exclusion of studies that did 
not adjust for smoking gave comparable results. Furthermore, this re-
view included all types of observational study designs, namely case- 
control, cross-sectional, and cohort studies. We performed stratified 
analyses by study design when comparing highest versus lowest cate-
gories of cadmium exposure in both diabetes and prediabetes, but we 
had insufficient data for the dose-response meta-analysis. Indeed, cohort 
studies were too limited to perform dose-response meta-analysis strati-
fied by type of exposure matrix, i.e. urinary or blood concentrations. 
Thus, we urge some caution when interpreting results from the dose- 
response analysis. In addition, findings differed by study design, as 
summary estimates from cohort studies yielded smaller RRs for dia-
betes/prediabetes compared with case-control and cross-sectional 
studies, thus we cannot entirely rule out reverse causation as an expla-
nation of the positive findings. Moreover, other pollutants that are 
correlated with cadmium may have confounded our results. In partic-
ular, other trace elements and heavy metals that are correlated with 
cadmium have been suggested to increase type 2 diabetes risk, including 
arsenic and selenium (Kuo et al. 2017; Roy et al. 2017; Vinceti et al. 
2018; Vinceti et al. 2021), and other endocrine-disrupting chemicals like 
phthalates and polychlorinated biphenyls (Sargis and Simmons 2019). 
Finally, we cannot entirely rule out publication bias, especially for 
studies using urinary cadmium concentrations and diabetes due to the 
magnitude of Egger’s test. However, estimates from trim-and-fill anal-
ysis showed identical or comparable estimates, although in some cases, 
they were less precise. 
5. Conclusions 
Overall, our review and meta-analysis found a positive association 
between cadmium exposure and risk of both type 2 diabetes and pre-
diabetes with a dose-response relation and moderate-certainty evidence. 
Diabetes risk increased linearly in studies using urinary cadmium con-
centrations, while disease risk increased only at the highest exposure 
levels when assessed using blood concentrations. The analysis for pre-
diabetes also showed a linear increase in risk from low exposure, with a 
flattening effect at higher urinary cadmium concentrations. Although 
our results are limited by the inability to perform stratified analysis in 
specific subgroups, such as non-smokers, or restricted to prospective 
cohort studies, these findings add to the available evidence on potential 
adverse health effects of environmental exposure to cadmium. Future 
research focusing on the assessment of the health effects of cadmium 
among non-smokers, especially at low levels of exposure, and using 
prospective cohort study designs would be worthwhile. 
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